News from us and our partners

Tags

Topics

0 results

News
9 April, 2020
RefleXion Announces First Sale of X1 Machine for Cancer Treatment
News
7 April, 2020
Shockwave Completes Enrollment in Pivotal Study for Coronary Intravascular Lithotripsy
News
3 April, 2020
Tissium Receives CE Mark and Announces Manufacturing Compliance Certification from TÜV SÜD
News
2 April, 2020
Calliditas strengthens its US Commercial Organization
News
31 March, 2020
Pixium Vision announces positive follow-up data from Prima System study in dry AMD
News
31 March, 2020
ProQR Announces Positive Findings From an Interim Analysis in the Phase 1/2 trial of QR-421a for Usher Syndrome and Provides Business Update
News
31 March, 2020
Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines
News
14 March, 2020
FDA Clearance Brings RefleXion Closer to Expanding Cancer Treatment Market
News
5 March, 2020
Biotalys announces second closing of €45 million Series C financing round
News
19 February, 2020
Bommy Lee Joins Sofinnova Partners as Head of Communications
News
23 January, 2020
Biotalys announces collaboration with Chrysal to evaluate potential of biofungicide in flowers
News
15 January, 2020
Sofinnova Partners Announces the Promotion of Michael Krel to Partner of Industrial Biotechnology Team
News
7 January, 2020
HOOKIPA’s Gilead Sciences Collaboration for HIV and HBV Therapeutic Vaccines Advancing Towards Clinical Entry
News
16 December, 2019
MedDay Reports Last Patient Study Visit in Phase 3 Clinical Trial with MD1003®*, an Important Step Towards Completion of the SPI2 Study in Progressive Multiple Sclerosis
News
22 November, 2019
Inotrem Announces Enrollment of First Patient in its Phase IIb ASTONISH Trial for Nangibotide in the Treatment of Septic Shock
News
21 November, 2019
TISSIUM Closes €39M Series B Funding Round

RefleXion Announces First Sale of X1 Machine for Cancer Treatment

Shockwave Completes Enrollment in Pivotal Study for Coronary Intravascular Lithotripsy

Tissium Receives CE Mark and Announces Manufacturing Compliance Certification from TÜV SÜD

Calliditas strengthens its US Commercial Organization

Pixium Vision announces positive follow-up data from Prima System study in dry AMD

ProQR Announces Positive Findings From an Interim Analysis in the Phase 1/2 trial of QR-421a for Usher Syndrome and Provides Business Update

Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines

FDA Clearance Brings RefleXion Closer to Expanding Cancer Treatment Market

Biotalys announces second closing of €45 million Series C financing round

Bommy Lee Joins Sofinnova Partners as Head of Communications

Biotalys announces collaboration with Chrysal to evaluate potential of biofungicide in flowers

Sofinnova Partners Announces the Promotion of Michael Krel to Partner of Industrial Biotechnology Team

HOOKIPA’s Gilead Sciences Collaboration for HIV and HBV Therapeutic Vaccines Advancing Towards Clinical Entry

MedDay Reports Last Patient Study Visit in Phase 3 Clinical Trial with MD1003®*, an Important Step Towards Completion of the SPI2 Study in Progressive Multiple Sclerosis

Inotrem Announces Enrollment of First Patient in its Phase IIb ASTONISH Trial for Nangibotide in the Treatment of Septic Shock

TISSIUM Closes €39M Series B Funding Round